![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
A2 Biotherapeutics emerges from Stealth Mode to develop tumour cell therapeutics
A2 Biotherapeutics, a biotechnology company developing innovative cell therapies for cancer patients, announced its official...
CDMOs to benefit from rising BTDs, orphan drugs and fast track status
CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th – 7th...
Bioeq announces Coherus as marketing and distribution partner for its biosimilar to Lucentis in...
Zürich, Switzerland. Bioeq IP AG has announced that it signed a license and development agreement...
Sygnature Discovery invests in high-throughput screening capability
Sygnature Discovery has added in-house high-throughput screening (HTS) to its range of drug discovery services....
BD Launches innovative two-step disposable autoinjector
Becton, Dickinson and Company (BD) has launched the BD Intevia 1 mL two-step disposable autoinjector,...
Shionogi and Hsiri to develop mycobacterial disease therapies
Japanese pharmaceutical firm Shionogi has signed a licence agreement with Hsiri Therapeutics for the discovery...
Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells
GammaDelta Therapeutics, a company focussed on harnessing the unique properties of gamma delta T-cells to...
Insilico Medicine and ChemDiv form a strategic drug discovery service alliance
Insilico Medicine and ChemDiv, Inc. launched a new strategic collaboration to provide certain pharmaceutical and...
U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients
Bayer AG and its development partner Janssen Research & Development, LLC announced that the U.S....
Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform...
Arctoris Ltd, a fully automated drug discovery platform for virtual and traditional biotechnology companies, pharmaceutical...